Enhancing Early Lung Cancer Diagnosis: Predicting Lung Nodule Progression in Follow-Up Low-Dose CT Scan with Deep Generative Model

Author:

Wang Yifan12ORCID,Zhou Chuan1ORCID,Ying Lei2,Chan Heang-Ping1,Lee Elizabeth1,Chughtai Aamer13,Hadjiiski Lubomir M.1,Kazerooni Ella A.14

Affiliation:

1. Department of Radiology, The University of Michigan Medical School, Ann Arbor, MI 48109-0904, USA

2. Department of Electrical Engineering and Computer Science, The University of Michigan, Ann Arbor, MI 48109-2122, USA

3. Diagnostic Radiology, Cleveland Clinic, Cleveland, OH 44195, USA

4. Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, MI 48109-0904, USA

Abstract

Early diagnosis of lung cancer can significantly improve patient outcomes. We developed a Growth Predictive model based on the Wasserstein Generative Adversarial Network framework (GP-WGAN) to predict the nodule growth patterns in the follow-up LDCT scans. The GP-WGAN was trained with a training set (N = 776) containing 1121 pairs of nodule images with about 1-year intervals and deployed to an independent test set of 450 nodules on baseline LDCT scans to predict nodule images (GP-nodules) in their 1-year follow-up scans. The 450 GP-nodules were finally classified as malignant or benign by a lung cancer risk prediction (LCRP) model, achieving a test AUC of 0.827 ± 0.028, which was comparable to the AUC of 0.862 ± 0.028 achieved by the same LCRP model classifying real follow-up nodule images (p = 0.071). The net reclassification index yielded consistent outcomes (NRI = 0.04; p = 0.62). Other baseline methods, including Lung-RADS and the Brock model, achieved significantly lower performance (p < 0.05). The results demonstrated that the GP-nodules predicted by our GP-WGAN model achieved comparable performance with the nodules in the real follow-up scans for lung cancer diagnosis, indicating the potential to detect lung cancer earlier when coupled with accelerated clinical management versus the current approach of waiting until the next screening exam.

Funder

National Institutes of Health

Publisher

MDPI AG

Reference44 articles.

1. (2022, September 01). Cancer Stat Facts: Lung and Bronchus Cancer, Available online: https://seer.cancer.gov/statfacts/html/lungb.html.

2. Howlader, N., Noone, A.M., Krapcho, M., Miller, D., Brest, A., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., and Lewis, D.R. (2022, September 01). SEER Cancer Statistics Review, 1975–2018, Available online: https://seer.cancer.gov/archive/csr/1975_2018/index.html.

3. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle;N. Engl. J. Med.,2011

4. Performance of ACR Lung-RADS in a clinical CT lung screening program;McKee;J. Am. Coll. Radiol.,2016

5. Prediction of future imagery of lung nodule as growth modeling with follow-up computed tomography scans using deep learning: A retrospective cohort study;Tao;Transl. Lung Cancer Res.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3